VarmX raises €32 million in Series B round led by Ysios Capital and INKEF Capital

by Ysios Capital

The oversubscribed round was co-led by Ysios Capital and INKEF Capital; Lundbeckfonden Ventures and LSP joined the syndicate. Founding investor, BioGeneration Ventures (BGV) and the regional economic ...

Read more

King & Wood Mallesons advises Ysios Capital on the launch of this third fund, Ysios BioFund III

by King & Wood Mallesons

The Funds team of King & Wood Mallesons ("KWM") is advising Ysios Capital ("Ysios") on the launch of its third fund, Ysios BioFund III, with a committed amount of €155 million and a final target siz...

Read more

Ona Therapeutics raises €30M in Series A financing supported by Alta Life Sciences, Asabys Partners, Bpifrance – InnoBio 2, Fund+ and Ysios Capital

by Asabys Partners

Ona Therapeutics, which is focused on the discovery and development of therapeutic biologics to treat metastatic cancer, announces today the closing of a €30 million Series A financing, with the par...

Read more

Ysios Capital presents its third fund of € 200M

by Ysios Capital

Ysios BioFund III will invest in companies that develop disruptive therapeutic products and platform technologies to address clear medical needs following an investment policy similar to its predecess...

Read more

AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI

by Ysios Capital

€23m has been mainly provided by Cowen Healthcare Investments, an affiliate of Cowen Inc., which joins the existing investor syndicate of LSP and Andera Partners, Forbion, Ysios Capital, Kurma Partn...

Read more

AM-Pharma Raises €116m [$133m] to Conduct Pivotal Phase III Trial of recAP in Acute Kidney Injury

by Ysios Capital

Financing co-led by new investors LSP and Andera Partners, with participation of existing investors Forbion, Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures and Gilde Healthca...

Read more

Pfizer secures exclusive option to acquire gene therapy company vivet therapeutics

by Ysios Capital

Vivet is supported by international life science investors including Novartis Venture Fund, Roche Venture Fund, HealthCap, Columbus Venture Partners, Ysios Capital, Kurma Partners and Idinvest Partner...

Read more

Minoryx Therapeutics raises €21.3M in Series B funding round

by Ysios Capital

The funding round was led by Fund+, joined by SFPI-FPIM, S.R.I.W. and Sambrinvest, in addition to all Series A investors (Ysios Capital, Kurma Partners, Roche Venture Fund, Idinvest Partners, Chiesi V...

Read more

Ysios Capital strengthens its team with the appointment of Guillem Laporta as Principal and two new Venture Partners

by Ysios Capital

Ysios Capital, a leading biotechnology venture capital firm in Spain, has announced that it has appointed Guillem Laporta as Principal and two new Venture Partners: Lance Berman and Claudia D’August...

Read more

Lundbeck to acquire Prexton Therapeutics, participated by Ysios Capital, in a deal valued at up to €905 million

by Ysios Capital

H. Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) have announced the signing of a definitive agreement in which Lundbeck will acquire Prexton. Under terms of the agreement, Lundbeck wil...

Read more

QIAGEN enters into agreement to acquire STAT-Dx, plans to launch a next-generation, fully integrated multiplex platform for syndromic disease testing

by Ysios Capital

QIAGEN N.V. has announced it has entered into an agreement to acquire STAT-Dx, a privately-held company developing the next generation of multiplex diagnostics for one-step, fully integrated molecular...

Read more

Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs. Ysios Capital participates in the round

by Ysios Capital

The funding round was led by a global strategic investor with participation from venture capital fund Ysios Capital and a number of large private investors. Existing institutional investors (LSP, Kurm...

Read more
Subscribe to Directory
Write an Article

Highlight

Ardian crea el grupo MonBake tras cerrar...

by Ardian

Ardian, uno de los mayores fondos de inversión de Europa, cerró ayer...

El Grupo Gallardo Balboa, controlado por...

by KKR

Cristian Lay se ha comprometido a asumir el resto de la deuda, que inc...

Photos Stream